Do truncated cyclins contribute to aberrant cyclin expression in cancer?

scientific article

Do truncated cyclins contribute to aberrant cyclin expression in cancer? is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.4161/CC.5.5.2516
P698PubMed publication ID16552186
P5875ResearchGate publication ID7227227

P2093author name stringPhilip J Browning
Jill C Pelling
Rukiyah Van Dross
P433issue5
P304page(s)472-477
P577publication date2006-03-01
P1433published inCell CycleQ1254166
P1476titleDo truncated cyclins contribute to aberrant cyclin expression in cancer?
P478volume5

Reverse relations

cites work (P2860)
Q35810749Among B-type cyclins only CLB5 and CLB6 promote premeiotic S phase in Saccharomyces cerevisiae
Q34467866Cell cyclins: triggering elements of cancer or not?
Q37732060Cell-cycle markers and biosensors
Q37702832Flow cytometric evaluation of cell cycle regulators (cyclins and cyclin-dependent kinase inhibitors) expressed on bone marrow cells in patients with chronic myeloid leukemia and multiple myeloma
Q37120421Inverse relationship between TCTP/RhoA and p53 /cyclin A/actin expression in ovarian cancer cells
Q37201211Nucleolus, ribosomes, and cancer
Q42818733Systematic classification of melanoma cells by phenotype-specific gene expression mapping.
Q26827580Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors

Search more.